FOLD
Amicus Therapeutics, IncData: 2026-04-24
Quick Stats
51.5
AI Score
HOLD1.67
Volume Ratio
TBA
Next Earnings
10
+ve Days (30d)
7
-ve Days (30d)
FOLD Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
FOLD Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
FOLD Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Daily Out of Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Daily In the Money Options - Sort by Max open Interest (near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Most Active Options by Volume(near term)
12th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
FOLD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
FOLD Stock Summary
Last updated
FOLD is currently trading at $14.49, positioned below its 200-day moving average of $, suggesting bearish momentum. The stock has a 52-week range of $5.51 to $14.5.
Technical Analysis: The 50-day moving average stands at $, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads , suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is , which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates FOLD at 51.5/100 with a HOLD recommendation.
FOLD Candlestick Patterns
No validated candlestick patterns fired for FOLD in the last 10 sessions — that's normal. Only the ~15 patterns with a backtested edge (out of 60 textbook patterns) are tracked here.
Amicus Therapeutics, Inc is below both the 50 Day and 200 Day SMA which is considered Bearish.
FOLD Moving Averages Analysis
FOLD (Amicus Therapeutics, Inc) Simple Moving Averages
Moving Averages are last updated
| Days | MA |
|---|
FOLD Fundamental Analysis
| P/E (Forward) | 30.4878 |
| P/E (Trailing) | -- |
| Market Cap ($) | 4.5 billion |
| Earnings/Share ($) | -0.09 |
| Net Profit Margin (%) | -0.0428 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.0726 |
| EPS Estimate Next Year ($) | 0.8189 |
| WallStreet Target Price ($) | 14.50 |
| Most Recent Quarter |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.